Amide cross-linking: An alternative to glutaraldehyde fixation

Journal of Heart Valve Disease

Volumn 5, Issue 5, 1996, Pages 518-525

  Girardot, Jean Marie D ^a   Girardot, Marie Nadia ^a  

^a Biomedical Design   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; 1,6 HEXANEDIAMINE; GLUTARALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ROOT; ARTICLE; BIOPROSTHESIS; CALCIFICATION; CONTROLLED STUDY; CROSS LINKING; NONHUMAN; PERICARDIUM; PRIORITY JOURNAL; RAT; SWINE; THERMOSTABILITY; TISSUE FIXATION;

AMIDES; ANIMALS; AORTIC VALVE; BIOPROSTHESIS; CALCINOSIS; CALCIUM; CAPRYLATES; CROSS-LINKING REAGENTS; DIAMINES; DICARBOXYLIC ACIDS; ETHYLDIMETHYLAMINOPROPYL CARBODIIMIDE; FIXATIVES; GLUTARAL; MALE; PERICARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SUCCINIMIDES; TISSUE FIXATION;

EID: 0029843929     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Nimni ME. A defect in the intramolecular cross-linking of collagen caused by penicillamine. I. Metabolic and functional abnormalities in soft tissues. J Biol Chem 1968;243:1457-1466
2. Nimni ME, Cheung D, Strates B, et al. Chemically modified collagen: a natural biomaterial for tissue replacement. J Biomed Mater Res 1987;21:741-771
3. Woodroof EA. Use of glutaraldehyde and formaldehyde to process tissue heart valves. J Bioeng 1978;2:1-4
4. Bortolotti U, Talenti E, Milano A, et al. Formaldehyde-versus glutaraldehyde-processed porcine bioprostheses in the aortic valve position: long-term follow-up. Am J Cardiol 1984;54:681-682
5. Carpentier A, Dubost C. From xenograft to bioprostheses: evolution of concepts and techniques of vascular xenografts. In: Ionescu DN, et al. (eds). Biological tissue in heart valve replacement. London: Butterworth & Co. Ltd, 1972:515-541
6. Cosgrove DM, Lytle BW, Golding CC, et al. In vivo hemodynamic comparison of porcine and pericardial valves. J Thorac Cardiovasc Surg 1983;64:172-176
7. Cooke A, Oliver RF, Edward M. An in vivo cytotoxicity study of aldehyde-treated pig dermal collagen. Br J Exp Pathol 1983;64:172-176
8. Eybl E, Griesmacher A, Grimm M, Wolner E. Toxic effects of aldehydes released from fixed pericardium on bovine endothelial cells. J Biomed Mater Res 1989;23:1355-1365
9. Gendler E, Gendler S, Nimni ME. Toxic reactions evoked by glutaraldehyde-fixed pericardium and cardiac valve tissue bioprostheses. J Biomed Mater Res 1984;18:727-736
10. Nistal F, Garcia-Martinez V, Fernandez D, et al. Degenerative pathologic findings after long-term implantation of bovine pericardial bioprosthetic heart valves. J Thorac Cardiovasc Surg 1988;96:642-651
11. Wiebe D, Mergerman J, L'Italien GJ, Abbott WM. Glutaraldehyde-release from vascular prostheses of biological origin. Surgery 1988;104:26-33
12. Schoen FJ, Levy RJ, Piehler HR. Pathologic considerations in replacement cardiac valves. J Soc Cardiovasc Pathol 1992;1:29-52
13. Gott JP, Pan-Chih, Dorsey L, et al. Calcification of porcine valves: a successful new method of antimineralization. Ann Thorac Surg 1992;53:207-216
14. Girardot MN, Girardot JM, Schoen FJ. Development of the AOA process as antimineralization treatment for bioprosthetic heart valves. Trans Soc Biomat 1993;16:266
15. Girardot JM, Girardot MN, Gott JP, et al. Preclinical testing for antimineralization treatments of heart valve bioprostheses. In: Wise DL, et al. (eds). Encyclopedic Handbook of Biomaterials and Bioengineering. Part B: Applications. Vol. 2. New York, Marcel Dekker, 1995:1189-1230
16. Chen W, Schoen FJ, Levy RJ. Mechanism of efficacy of 2-aminooleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation 1994;90:323-329
17. Hazenkamp MG, Coffin YA, Huysmans HA. The value of the stentless biovalve prosthesis. An experimental study. Eur J Cardiothorac Surg 1993;7:514-519
18. Westaby S, Amarasena N, Long V, et al. Time-related hemodynamic changes after aortic replacement with the Freestyle stentless xenograft. Ann Thorac Surg 1995;60:1633-1639
19. Sintek CF, Fletcher AD, Khonsari S. Stentless porcine aortic root: valve of choice for the elderly patient with small aortic root? J Thorac Cardiovasc Surg 1995;109:871-876
20. Sawatani O. Usefulness of epoxy compounds as a new cross-linking agent for xenograft bioprosthesis. Jpn J Artif Organs 1991;20:1452-1459
21. Petite H, Rault I, Hue A, et al. Use of the acyl azide method for cross-linking collagen-rich tissues such as pericardium. J Biomed Mater Res 1990;24:179-187
22. Moore MA, Bohachevsky IK, Cheung DT, et al. Stabilization of pericardial tissue by dye-mediated photooxidation. J Biomedical Mater Res 1994;28:611-618
23. Schoen FJ., Tsao JW, Levy RJ. Calcification of bovine pericardium used in cardiac valve bioprosthesis: implications for the mechanisms of bioprothetic tissue mineralization. Am J Pathol 1986;123:134-145
24. Girardot JM, Girardot MN, Anderson JM. A new noglutaraldehyde cross-linking method with amide bond formation for heart valve bioprostheses. ASAIO 1996;42:124
25. Schryer PJ, Tomaseck ER, Starr JA, et al. Anticalcification effect of glutaraldehyde-preserved valve tissue stored for increasing time in glutaraldehyde. In: Bodnar E, Yacoub M (eds). Biologic and Bioprosthetic Valves. Yorke Medical Books 1986:471-472
26. Girardot MN, Torrianni M, Dillehay D, et al. Role of glutaraldehyde in calcification of porcine heart valves: comparing cusps and wall. J Biomed Mater Res 1995;29:793-801